Development and delivery of a customized robotic patient positioning system as part of the Alphabeam™ neutron system for high-precision radiation treatment of tumors. TAE Life Sciences (TLS) is developing the next generation of targeted boron drugs and an accelerator-based low-energy neutron source - optimized for an in-hospital BNCT program that will one day treat patients with the most aggressive and recurrent cancers.